Efficacy of dexmedetomidine premedication on attenuation of intraocular pressure changes after succinylcholine and endotracheal intubation
Journal Title: Indian Journal of Clinical Anaesthesia - Year 2018, Vol 5, Issue 1
Abstract
Introduction: Succinylcholine, is one of the most commonly used muscle relaxant for rapid sequence airway management. It increases the Intraocular pressure (IOP) which is deleterious in open globe injuries. We studied the effects of Inj. dexmedetomidine, a highly selective α2-adrenoceptor agonist, on IOP and hemodynamic responses to succinylcholine and tracheal intubation. Materials and Methods: Sixty ASA I–II patients, scheduled for elective non-ophthalmic surgeries requiring general anesthesia were randomly premedicated by intravenous Inj. dexmedetomidine 0.4 µg/kg (Group-D) or saline (Group-S) (30 patients each group). Heart rate (HR), mean arterial pressure (MAP), and IOP (using Schiotz tonometer) were measured 10 minutes before and after the premedication, 30 seconds after succinylcholine and at 1, 5 and 10 minutes after intubation. Results: Ten minutes after Inj. dexmedetomidine administration, there was marked decrease in IOP. After intubation there was a rise in IOP, however it remained below baseline IOP (p=0.315) and remained low at 10th minute after intubation (p<0.001) which was statistically significant. In the control group, there was a significant rise in IOP following Inj. succinylcholine and intubation which remained above baseline IOP even at 10th minute after intubation. HR, Systolic and diastolic blood pressure, and MAP markedly increased at 1 minute following intubation in the control group whereas in dexmedetomidine group, they remained below baseline (p<0.001). Conclusions: Intravenous dexmedetomidine at a dose of 0.4 μg/kg can be used for attenuation of rise in IOP associated with succinylcholine and tracheal intubation in patients with open globe injuries.
Authors and Affiliations
Sreenivas Reddy M. , Pradeep Hosagoudar, Giridhar J. B. , Y. V. Murali, K. V. Srinivasan
Comparison of Efficacy and Safety of 0.5% Bupivacaine and 0.5% Ropivacaine for Combined Femoral Nerve Block and Sciatic Nerve Block (Anterior Approach): A randomized controlled trial
Various local anesthetic agents in different concentrations have been used for combined femoral and sciatic nerve block. But the existing evidence is inconclusive on the ideal anesthetic agent and its concentration. The...
A study of effectiveness of 0.5% bupivacaine for sensory blockade as local anesthesia in epidural and spinal phase
Background: Bupivacaine is a long-acting local anesthetic. Addition of epinephrine is thus rarely required. It blocks initiation and transmission of nerve impulses at the site of application by stabilizing the neuronal m...
A study to evaluate the effectiveness of Bupivacaine (0.5%) versus Ropivacaine (0.5%, 0.75%) in patients undergoing upper limb surgery under brachial plexus block
Introduction: Brachial plexus block is the commonest form of regional anaesthesia being used for upper limb surgeries. Bupivacaine is most widely used local anaesthetic in regional anaesthesia, but its cardiotoxicity has...
Anaesthetic management of an Extremely Low Birth Weight (ELBW) neonate with multiple co-morbidities
Anaesthetic management of an extremely low birth weight (ELBW) neonate is always a challenge. Challenges are substantial beginning from pre-operative preparation till the neonate has been shifted to the neonatal intensiv...
Dexmedetomidine as an adjunct to anaesthetic induction to attenuate haemodynamic responses to Endotracheal Intubation
Introduction: The hemodynamic responses to endotracheal intubation (EI) may impose myocardial ischemia, infarction (MI); arrhythmias or precipitate cardiac failure. Dexmedetomidine, which is a D-isomer of medetomidine is...